Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2010 | 09-2007 | 09-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | 7,904 | N/A | N/A |
| Depreciation Amortization | 553 | N/A | N/A |
| Accounts receivable | -6 | N/A | N/A |
| Accounts payable and accrued liabilities | 181 | N/A | N/A |
| Other Working Capital | -18,411 | N/A | N/A |
| Other Operating Activity | -396 | 0 | 0 |
| Operating Cash Flow | $-10,175 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -37 | N/A | N/A |
| Purchase Of Investment | -603 | N/A | N/A |
| Sale Of Investment | 2,303 | N/A | N/A |
| Investing Cash Flow | $1,663 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -7 | N/A | N/A |
| Common Stock Issued | 15 | N/A | N/A |
| Financing Cash Flow | $8 | $N/A | $N/A |
| Beginning Cash Position | 8,970 | N/A | N/A |
| End Cash Position | 466 | N/A | N/A |
| Net Cash Flow | $-8,504 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -10,175 | N/A | N/A |
| Capital Expenditure | -37 | N/A | N/A |
| Free Cash Flow | -10,212 | 0 | 0 |